Trust Point’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$327K Buy
16,599
+4,044
+32% +$92.2K 0.02% 348
2026
Q2
$323K Sell
12,555
-11,062
-47% -$256K 0.03% 323
2026
Q1
$486K Sell
23,617
-1,337
-5% -$30.1K 0.04% 260
2025
Q4
$592K Buy
24,954
+220
+0.9% +$5.36K 0.05% 194
2025
Q3
$616K Sell
24,734
-1,167
-5% -$25.1K 0.05% 185
2025
Q2
$596K Sell
25,901
-13,015
-33% -$301K 0.06% 160
2025
Q1
$874K Sell
38,916
-2,286
-6% -$53.1K 0.08% 127
2024
Q4
$806K Buy
41,202
+72
+0.2% +$1.43K 0.06% 195
2024
Q3
$749K Buy
41,130
+1,386
+3% +$26.4K 0.06% 209
2024
Q2
$691K Sell
39,744
-1,180
-3% -$20.9K 0.06% 210
2024
Q1
$802K Buy
40,924
+15,527
+61% +$328K 0.06% 194
2023
Q4
$585K Buy
+25,397
New +$568K 0.05% 238

Other funds holding PRVA

Trust Point's PRVA Position: Q3 2026 in Review

Trust Point increased its Privia Health (PRVA) stake by 32% in Q3 2026, buying an estimated $92.2K and bringing the position to 16,599 shares worth $327K. The position accounts for 0.02% of the portfolio, ranked #348.

Trust Point first reported a position in PRVA in Q4 2023 and has held it in 12 quarters since. The position peaked at $874K in Q1 2025. 232 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

  • Trust Point held 16,599 shares of Privia Health worth $327K as of Q3 2026.
  • Trust Point bought 4,044 Privia Health shares in Q3 2026, an estimated $92.2K.
  • Privia Health made up 0.02% of Trust Point's portfolio in Q3 2026, its #348 holding.
  • Trust Point first reported a position in Privia Health in Q4 2023 and has held it in 12 quarters since.
  • Trust Point's Privia Health position peaked at $874K in Q1 2025.
  • 232 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.